Senolytic compounds control a distinct fate of androgen receptor agonist- and antagonist-induced cellular senescent LNCaP prostate cancer cells

por Pungsrinont, Thanakorn, Sutter, Malika Franziska, Ertingshausen, Maren C. C. M., Lakshmana, Gopinath, Kokal, Miriam, Khan, Amir Saeed, Baniahmad, Aria
Publicado 2020